Ledipasvir + Sofosbuvir Tablet Franchise in Ahmedabad

Hepatitis C Antiviral Supplier in Mumbai

Soldevir Tablet Distributor in Delhi

Combination Hepatitis C Tablet Franchise Opportunity in Bangalore

Hepatitis C Treatment Tablet Stockist in Hyderabad
Ledipasvir + Sofosbuvir Export & Manufacturing in Chandigarh

Home/Products /ledipasvir-90mg-sofosbuvir-400mg-tablet

Soldevir Tablet

Composition : Ledipasvir (90mg) + Sofosbuvir (400mg) Tablet

Dosage Form : Tablet

Packaging Type : in a Bottle

Packaging : 30 Tablets

Price : ₹1/-

Soldevir Tablet contains a combination of Ledipasvir 90mg and Sofosbuvir 400mg, a highly effective direct-acting antiviral (DAA) formulation indicated for the management of Hepatitis C infection. It helps in suppressing viral replication, reducing viral load, and supporting liver function.

The combination works by inhibiting HCV NS5A and NS5B polymerase, providing comprehensive viral suppression and aiding in the achievement of sustained virologic response (SVR). Regular therapy with Soldevir Tablet contributes to improved liver health and long-term disease control.

For distributors and healthcare suppliers, Soldevir Tablet is a high-demand antiviral product, widely prescribed in hospitals, specialty liver clinics, and gastroenterology centers. The increasing prevalence of Hepatitis C and the need for potent combination therapies ensure consistent year-round demand.

Adding Soldevir Tablet to your hepatoprotective and antiviral segment offers excellent opportunities in pharmacies, hospitals, liver care clinics, export markets, and third-party manufacturing. Its clinically proven efficacy, patient acceptance, and broad therapeutic application make it a valuable addition for pharmaceutical distribution.


Read More

About the Product

Soldevir Tablet contains a combination of Ledipasvir 90mg and Sofosbuvir 400mg, a highly effective direct-acting antiviral (DAA) formulation indicated for the management of Hepatitis C infection. It helps in suppressing viral replication, reducing viral load, and supporting liver function.

The combination works by inhibiting HCV NS5A and NS5B polymerase, providing comprehensive viral suppression and aiding in the achievement of sustained virologic response (SVR). Regular therapy with Soldevir Tablet contributes to improved liver health and long-term disease control.

For distributors and healthcare suppliers, Soldevir Tablet is a high-demand antiviral product, widely prescribed in hospitals, specialty liver clinics, and gastroenterology centers. The increasing prevalence of Hepatitis C and the need for potent combination therapies ensure consistent year-round demand.

Adding Soldevir Tablet to your hepatoprotective and antiviral segment offers excellent opportunities in pharmacies, hospitals, liver care clinics, export markets, and third-party manufacturing. Its clinically proven efficacy, patient acceptance, and broad therapeutic application make it a valuable addition for pharmaceutical distribution.


Common side effects may include headache, fatigue, insomnia, nausea, and diarrhea. Rarely, patients may experience serious effects such as bradycardia, liver function abnormalities, or severe allergic reactions. Patients should consult their healthcare provider if any unusual or persistent symptoms occur.

Soldevir Tablet is indicated for the treatment of chronic hepatitis C infection, particularly genotypes 1, 4, 5, and 6. It helps in reducing viral load, achieving sustained virologic response (SVR), and preventing liver-related complications such as cirrhosis or hepatocellular carcinoma.

Before starting Soldevir Tablet, inform your doctor about any existing liver or kidney conditions, other medications, or allergies. It is important to follow the full course of therapy without interruption to prevent viral relapse or resistance. Regular monitoring of liver function and viral load is recommended during treatment.

Store Soldevir Tablet in a cool, dry place, away from direct sunlight and moisture. Keep it out of reach of children and ensure the container is tightly closed. Do not use the medication beyond its expiration date.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation